Diol-Based HIV-1 protease inhibitor 4 Uses, Dosage, Side Effects and more
| Attribute | Details |
|---|---|
| Trade Name | Diol-Based HIV-1 protease inhibitor 4 |
| Generic | (2R,3R,4R,5R)-3,4-Dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(2-phenylethyl)hexanediamide |
| (2R,3R,4R,5R)-3,4-Dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(2-phenylethyl)hexanediamide Other Names | Diol-Based HIV-1 protease inhibitor 4 |
| Type | |
| Formula | C40H44N2O6 |
| Weight | Average: 648.7872 Monoisotopic: 648.31993715 |
| Groups | Experimental |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
